Endonovo Therapeutics, Inc. SEC filings ENDV

Endonovo Therapeutics, Inc. has 502 filings in SEC EDGAR's recent list, going back to Sep 22, 2011. Its latest annual report, Form 10-K, was filed on Apr 17, 2023 for the period ended Dec 31, 2022. The latest quarterly report (Form 10-Q) was filed on Dec 29, 2023, covering the quarter ended Sep 30, 2023. The most recent current report (Form 8-K) was filed on Jan 3, 2024 (material agreement). The company's fiscal year ends on December 31.

Endonovo Therapeutics, Inc. SEC filings
Form Description Filed Period
SEC STAFF ACTION Filing Sep 19, 2024 —
15-12G Deregistration Feb 2, 2024 —
8-K Current report
Material agreement
Jan 3, 2024 Dec 29, 2023
10-Q/A Amended quarterly report Dec 29, 2023 Sep 30, 2023
10-Q Quarterly report Dec 29, 2023 Sep 30, 2023
8-K Current report
Material agreement
Dec 4, 2023 Dec 4, 2023
NT 10-Q Filing Nov 15, 2023 Sep 30, 2023
8-K Current report
Other events
Oct 12, 2023 Oct 5, 2023
1-A/A Filing Aug 25, 2023 —
10-Q Quarterly report Aug 21, 2023 Jun 30, 2023
NT 10-Q Filing Aug 15, 2023 Jun 30, 2023
1-A/A Filing Jun 14, 2023 —
10-Q Quarterly report May 22, 2023 Mar 31, 2023
NT 10-Q Filing May 16, 2023 Mar 31, 2023
10-K Annual report Apr 17, 2023 Dec 31, 2022
NT 10-K Filing Mar 31, 2023 Dec 31, 2022
8-K Current report
Material agreement
Mar 29, 2023 Mar 28, 2023
10-Q Quarterly report Nov 21, 2022 Sep 30, 2022
NT 10-Q Filing Nov 14, 2022 Sep 30, 2022
8-K Current report
Material agreement
Sep 27, 2022 Sep 26, 2022
10-Q Quarterly report Aug 22, 2022 Jun 30, 2022
NT 10-Q Filing Aug 15, 2022 Jun 30, 2022
10-Q Quarterly report May 19, 2022 Mar 31, 2022
NT 10-Q Filing May 16, 2022 Mar 31, 2022
1-A/A Filing May 10, 2022 —
10-K Annual report Apr 14, 2022 Dec 31, 2021
NT 10-K Filing Mar 31, 2022 Dec 31, 2021
1-A Filing Feb 11, 2022 —
10-Q Quarterly report Nov 19, 2021 Sep 30, 2021
NT 10-Q Filing Nov 15, 2021 Sep 30, 2021
10-Q Quarterly report Aug 23, 2021 Jun 30, 2021
NT 10-Q Filing Aug 16, 2021 Jun 30, 2021
10-Q Quarterly report May 24, 2021 Mar 31, 2021
NT 10-Q Filing May 17, 2021 Mar 31, 2021
10-K Annual report Apr 13, 2021 Dec 31, 2020
NT 10-K Filing Mar 31, 2021 Dec 31, 2020
10-Q Quarterly report Nov 19, 2020 Sep 30, 2020
NT 10-Q Filing Nov 16, 2020 Sep 30, 2020
10-Q Quarterly report Aug 19, 2020 Jun 30, 2020
NT 10-Q Filing Aug 11, 2020 Jun 30, 2020
8-K Current report
Officer or director change
Aug 7, 2020 Aug 6, 2020
EFFECT Filing Jul 16, 2020 —
424B3 Prospectus Jul 16, 2020 —
CORRESP Letter to the SEC Jul 13, 2020 —
S-1/A Amended registration statement Jul 10, 2020 —
UPLOAD Letter from the SEC Jun 30, 2020 —
S-1 Registration statement Jun 23, 2020 —
10-Q Quarterly report Jun 12, 2020 Mar 31, 2020
EFFECT Filing Jun 8, 2020 —
RW WD Filing Jun 2, 2020 —
POS AM Filing Jun 2, 2020 —
RW Filing May 29, 2020 —
8-K Current report
Material agreement
May 26, 2020 May 20, 2020
8-K Current report
Other events
May 19, 2020 May 19, 2020
NT 10-Q Filing May 14, 2020 Mar 31, 2020
10-K Annual report May 4, 2020 Dec 31, 2019
8-K Current report
Other events
Apr 10, 2020 Apr 10, 2020
NT 10-K Filing Mar 26, 2020 Dec 31, 2019
8-K Current report
Other events
Mar 2, 2020 Mar 2, 2020
8-K Current report
Change to shareholder rights
Feb 3, 2020 Jan 29, 2020
8-K Current report
Change to shareholder rights
Dec 19, 2019 Dec 11, 2019
D Filing Nov 22, 2019 —
10-Q Quarterly report Nov 19, 2019 Sep 30, 2019
NT 10-Q Filing Nov 14, 2019 Sep 30, 2019
DEF 14C Information statement Nov 14, 2019 Nov 14, 2019
DEF 14A Proxy statement Nov 14, 2019 Nov 13, 2019
PRE 14C Filing Oct 31, 2019 Oct 30, 2019
10-Q Quarterly report Aug 13, 2019 Jun 30, 2019
8-K Current report
Other events
Jun 13, 2019 Jun 10, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
10-K Annual report Apr 15, 2019 Dec 31, 2018
NT 10-K Filing Mar 29, 2019 Dec 31, 2018
EFFECT Filing Feb 11, 2019 —
UPLOAD Letter from the SEC Feb 8, 2019 —
CORRESP Letter to the SEC Feb 6, 2019 —
S-1/A Amended registration statement Jan 8, 2019 —
S-1 Registration statement Jan 7, 2019 —
8-K Current report
Material agreement
Jan 3, 2019 Jan 1, 2019
8-K Current report
Material agreement
Dec 7, 2018 Dec 6, 2018
10-Q Quarterly report Nov 13, 2018 Sep 30, 2018
8-K Current report
Change to shareholder rights
Sep 24, 2018 Sep 18, 2018
DEF 14C Information statement Aug 28, 2018 Aug 28, 2018
PRE 14C Filing Aug 14, 2018 Aug 14, 2018
8-K Current report
Material agreement
Aug 14, 2018 Aug 12, 2018
10-Q Quarterly report Aug 13, 2018 Jun 30, 2018
10-Q Quarterly report May 18, 2018 Mar 31, 2018
NT 10-Q Filing May 16, 2018 Mar 31, 2018
10-K Annual report Apr 6, 2018 Dec 31, 2017
NT 10-K Filing Apr 3, 2018 Dec 31, 2017
D Filing Dec 29, 2017 —
8-K Current report
Material agreement
Dec 28, 2017 Dec 21, 2017
8-K Current report
Material agreement, Acquisition or sale of assets, Change to shareholder rights
Dec 26, 2017 Dec 22, 2017
10-Q/A Amended quarterly report Nov 9, 2017 Sep 30, 2017
10-Q Quarterly report Nov 7, 2017 Sep 30, 2017
10-Q Quarterly report Aug 10, 2017 Jun 30, 2017
10-Q Quarterly report May 12, 2017 Mar 31, 2017
10-K Annual report Apr 17, 2017 Dec 31, 2016
NT 10-K Filing Apr 3, 2017 Dec 31, 2016
8-K Current report
Change to shareholder rights
Feb 10, 2017 Feb 7, 2017
8-K Current report
Change to shareholder rights
Jan 18, 2017 Jan 17, 2017
UPLOAD Letter from the SEC Jan 11, 2017 —
DEF 14C Information statement Dec 19, 2016 Dec 19, 2016
PRE 14C Filing Dec 8, 2016 Dec 8, 2016
10-Q Quarterly report Nov 14, 2016 Sep 30, 2016
424B3 Prospectus Oct 19, 2016 —
EFFECT Filing Oct 17, 2016 —
S-1/A Amended registration statement Oct 17, 2016 —
CORRESP Letter to the SEC Oct 14, 2016 —
CORRESP Letter to the SEC Oct 6, 2016 —
S-1/A Amended registration statement Oct 6, 2016 —
UPLOAD Letter from the SEC Sep 23, 2016 —
S-1 Registration statement Aug 29, 2016 —
8-K Current report
Agreement ended
Aug 19, 2016 Aug 19, 2016
10-Q Quarterly report Aug 12, 2016 Jun 30, 2016
8-K Current report
Material agreement
Jul 15, 2016 Jul 12, 2016
8-K Current report
Material agreement
Jul 11, 2016 Jul 9, 2016
8-K Current report
Other events
Jun 13, 2016 Nov 30, 2015
10-Q/A Amended quarterly report May 27, 2016 Mar 31, 2016
10-Q Quarterly report May 20, 2016 Mar 31, 2016
10-K/A Amended annual report May 17, 2016 Dec 31, 2015
NT 10-Q Endv nt 10-q 03/31/16 May 16, 2016 Mar 31, 2016
10-K Annual report Apr 5, 2016 Dec 31, 2015
NT 10-K Endv nt 10-k 12/31/15 Mar 31, 2016 Dec 31, 2015
EFFECT Filing Mar 14, 2016 —
POS AM Endv pos am 03/11/16 Mar 11, 2016 —
D Filing Feb 19, 2016 —
10-Q Quarterly report Nov 23, 2015 Sep 30, 2015
NT 10-Q Endv nt 10-q 09/30/15 Nov 16, 2015 Sep 30, 2015
10-Q Quarterly report Aug 19, 2015 Jun 30, 2015
NT 10-Q Endv nt 10-q 06/30/15 Aug 14, 2015 Jun 30, 2015
8-A12G For registration of certain classes Jun 15, 2015 —
10-Q/A Amended quarterly report Jun 15, 2015 Mar 31, 2015
10-K/A Amended annual report Jun 15, 2015 Dec 31, 2014
10-Q Quarterly report May 19, 2015 Mar 31, 2015
NT 10-Q Endv nt 10-q 03/31/15 May 15, 2015 Mar 31, 2015
EFFECT Filing May 1, 2015 —
RW Endv rw 04/30/15 May 1, 2015 —
EFFECT Filing Apr 30, 2015 —
S-1/A Amended registration statement Apr 30, 2015 —
CORRESP Letter to the SEC Apr 27, 2015 —
S-1/A Amended registration statement Apr 24, 2015 —
10-K Annual report Apr 3, 2015 Dec 31, 2014
NT 10-K Endv nt 10-k 12/31/14 Mar 30, 2015 Dec 31, 2014
UPLOAD Letter from the SEC Feb 19, 2015 —
S-1 Registration statement Feb 13, 2015 —
8-K Current report
Material agreement
Jan 21, 2015 Jan 20, 2015
D Filing Dec 9, 2014 —
D Filing Dec 3, 2014 —
D/A Filing Dec 3, 2014 —
10-Q Quarterly report Nov 14, 2014 Sep 30, 2014
D Filing Sep 5, 2014 —
10-Q Quarterly report Aug 19, 2014 Jun 30, 2014
NT 10-Q Endo nt 10-q 06/30/14 Aug 14, 2014 Jun 30, 2014
D/A Filing Aug 11, 2014 —
10-Q Quarterly report May 15, 2014 Mar 31, 2014
10-K Annual report Apr 15, 2014 Dec 31, 2013
NT 10-K Endo nt 10-k 12/31/13 Mar 31, 2014 Dec 31, 2013
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Jan 24, 2014 Jan 22, 2014
10-Q Quarterly report Dec 18, 2013 Sep 30, 2013
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
Nov 19, 2013 Nov 16, 2013
D Filing Nov 15, 2013 —
NT 10-Q Hvpa nt 10-q 09/30/13 Nov 14, 2013 Sep 30, 2013
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Oct 11, 2013 Sep 20, 2013
10-Q/A Amended quarterly report Aug 28, 2013 Jun 30, 2013
10-Q Quarterly report Aug 19, 2013 Jun 30, 2013
NT 10-Q Hvpa nt 10-q 06/30/13 Aug 14, 2013 Jun 30, 2013
10-Q/A Amended quarterly report Jun 21, 2013 Mar 31, 2013
10-Q Quarterly report May 20, 2013 Mar 31, 2013
NT 10-Q Hvpa nt 10-q 03/31/13 May 16, 2013 Mar 31, 2013
10-K/A Amended annual report May 3, 2013 Dec 31, 2012
10-K Annual report Apr 16, 2013 Dec 31, 2012
10-K Annual report Apr 16, 2013 Dec 31, 2012
8-K/A Amended current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Other events
Apr 9, 2013 Apr 2, 2013
8-K Current report
Material agreement, Other events
Apr 8, 2013 Apr 2, 2013
NT 10-K Hpai nt 10-k 12/31/12 Apr 1, 2013 Dec 31, 2012
10-Q Quarterly report Nov 29, 2012 Sep 30, 2012
NT 10-Q/A Hpa nt 10-q 09/30/12 Nov 21, 2012 Sep 30, 2012
NT 10-Q Hanover nt10-q 09/30/12 Nov 15, 2012 Sep 30, 2012
10-Q Quarterly report Aug 20, 2012 Jun 30, 2012
NT 10-Q Hanover nt 10-q 06/30/12 Aug 14, 2012 Jun 30, 2012
10-Q Quarterly report May 21, 2012 Mar 31, 2012
NT 10-Q Hanover nt 10-q 03/31/12 May 15, 2012 Mar 31, 2012
10-K Annual report Apr 13, 2012 Dec 31, 2011
NT 10-K Hpa nt 10-k 12/31/11 Mar 30, 2012 Dec 31, 2011
8-K Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change
Mar 21, 2012 Mar 19, 2012
424B3 Prospectus Dec 28, 2011 —
EFFECT Filing Dec 7, 2011 —
CORRESP Letter to the SEC Dec 5, 2011 —
CORRESP Letter to the SEC Nov 29, 2011 —
UPLOAD Letter from the SEC Nov 23, 2011 —
S-1/A Amended registration statement Nov 14, 2011 —
CORRESP Letter to the SEC Nov 14, 2011 —
UPLOAD Letter from the SEC Oct 17, 2011 —
S-1 Registration statement Sep 22, 2011 —

Showing 194 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
ENDV (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Woodland Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1528172
Former names
Hanover Portfolio Acquisitions, Inc. (until Jan 24, 2014)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.